<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03859167</url>
  </required_header>
  <id_info>
    <org_study_id>190470</org_study_id>
    <nct_id>NCT03859167</nct_id>
  </id_info>
  <brief_title>Study of the Loss of AV Synchrony at Maximum Exercise</brief_title>
  <acronym>SLAVSME</acronym>
  <official_title>SLAVSME - Study of the Loss of AV Synchrony at Maximum Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will identify a group of patients with complete heart block and a dual chamber
      pacemaker who will be expected to be able to exercise on a treadmill. Investigators will
      utilize symptom logs, cuff and continuous blood pressure monitoring. It is planned to study
      the symptomatic impact of loss of AV synchrony at significant levels of exercise.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 10, 2019</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participants with Loss of AV synchrony at maximum exercise</measure>
    <time_frame>Baseline to end of stress test approximately 60 minutes.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Exercise</condition>
  <condition>Pacemaker</condition>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Participants with AV block with pacemaker</arm_group_label>
    <description>Participants will have a stress test, and results will be collected and recorded.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stress Test</intervention_name>
    <description>Participants will reach maximum exercise on a treadmill and results will be collected and recorded.</description>
    <arm_group_label>Participants with AV block with pacemaker</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients from cardiology clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complete AV Block

          -  Age less than 60

          -  Easily programmable dual chamber pacemaker

        Exclusion Criteria:

          -  Age &gt; 60

          -  Significant Heart Failure

          -  Significant angina

          -  History of claudication

          -  Significant orthopedic issues

          -  Evidence of sinus node dysfunction

          -  Taking beta blockers or non-dihydropyridine calcium channel blockers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jay A. Montgomery, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>February 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2019</study_first_posted>
  <last_update_submitted>December 9, 2019</last_update_submitted>
  <last_update_submitted_qc>December 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Jay Montgomery</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

